Streetbeat News

Products Services

LILM

Lilium and the Saudi Arabian General Authority of Civil Aviation have signed a Memorandum of Understanding (MoU) to develop and implement regulations for eVTOL operations in Saudi Arabia starting in 2026.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:04 pm

ATYR

aTyr Pharma has completed enrollment of 268 patients in its Phase 3 EFZO-FIT study for efzofitimod, exceeding the target. This is the largest interventional study in pulmonary sarcoidosis, with topline data expected in Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:04 pm

MIRA

MIRA Pharmaceuticals has announced new preclinical study results for its novel oral ketamine analog, Ketamir-2, which shows potential advantages for treating neurological and neuropsychiatric disorders.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:03 pm

IMMP

Immutep Limited has received positive feedback from the FDA regarding the design of its Phase III TACTI-004 trial for treating first-line non-small cell lung cancer (1L NSCLC) with eftilagimod alfa in combination with KEYTRUDA and standard chemotherapy. The trial will enroll approximately 750 patients regardless of PD-L1 expression.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:03 pm

TCBP

TC BioPharm (TCBP) has dosed the sixth patient in its ACHIEVE study, which focuses on treating patients with Acute Myeloid Leukemia (AML).

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:03 pm

ALLR

Allarity Therapeutics received a Wells Notice from the SEC regarding its disclosures about meetings with the FDA concerning its NDA for Dovitinib or Dovitinib-DRP. The company has a cash balance of $20 million, expected to last until 2026, and has paused its ATM usage. Additionally, Allarity's Stenoparib shows extended Phase 2 clinical benefits.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:02 pm

JNJ

Johnson & Johnson has submitted a supplemental new drug application to the FDA for the approval of SPRAVATO CIII nasal spray, aimed at treating treatment-resistant depression.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:01 pm

TACT

TransAct Technologies has started the rollout of its BOHA! Terminal 2 to all 42 Jet Food Stores for fresh food labeling, with full deployment expected by September.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:01 pm

SSKN

STRATA Skin Sciences has received approval for its XTRAC Momentum 1.0 device in Japan, potentially expanding its market reach and revenue opportunities.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 12:00 pm

RTX

Raytheon UK, a subsidiary of RTX Corp, successfully tested its High-Energy Laser Weapon System (HELWS) integrated onto a British Army combat vehicle. This marks the first test of its kind in the UK and a significant advancement in the UK's Land Laser Directed Energy Weapon (LDEW) Demonstrator programme.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 11:56 am